FDA 483 - Teva API India Private Ltd. - July 18, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Teva API India Private Limited, an API and intermediate manufacturer in Gajraula, India, received a Form FDA 483 with seven observations. The inspection revealed significant deficiencies across quality control, data integrity, equipment maintenance, personnel training, and facility upkeep. Key issues include inadequate quality unit oversight, uninvestigated equipment failures, widespread data integrity concerns with computerized systems and documentation, and poor facility maintenance.
ID · 4b254e77-1d5c-45ba-95f1-9b1ded174920